Difference between revisions of "Part:BBa K2278023"
 
(12 intermediate revisions by 2 users not shown)
Line 17: Line 17:
  
 
<h3 id="RT"> 2- Usage in iGEM projects </h3>
 
<h3 id="RT"> 2- Usage in iGEM projects </h3>
−
The part was designed during the Croc’n Cholera project <a href="http://2017.igem.org/Team:INSA-UPS_France">(team INSA-UPS-France 2017)</a>. It produces the cOT2 AMP when associated with a yeast promoter. The α-factor (BBa_K1800001) sequence contains a RBS and a signal sequence to secrete the produced peptides.
+
The part was designed during the Croc’n Cholera project <a href="http://2017.igem.org/Team:INSA-UPS_France">(team INSA-UPS-France 2017)</a>. It produces the cOT2 AMP when associated with a yeast promoter. The α-factor (</html><partinfo>BBa_K1800001</partinfo><html>) sequence contains a RBS and a signal sequence to secrete the produced peptides.
 
</html>
 
</html>
 
<br>
 
<br>
Line 31: Line 31:
 
<br>
 
<br>
 
<b>Analysis of the restriction map </b>
 
<b>Analysis of the restriction map </b>
−
<figure><p style="text-align:center;"><img src="https://static.igem.org/mediawiki/parts/c/c8/T--INSA-UPS_France--cOT2.png" width = "400"/><figcaption> Figure 1: <b>Analysis of the restriction map BBa_K2278023. </b> Digested fragments (Xba1 and Pst1) are electrophoresed through a 0.7% agarose gel. Control vector pSB1C3 contained an insert and expected size were 2034 and 700 bp (digestion was not total, hence the 2734 bp fragment). The fragment lengths of the tested clone were XXXX bp and XXXX bp for the required insert.</figcaption></figure>
+
 
 +
</html>
 +
[[Image:T--INSA-UPS_France--cOT2.png|800px|thumb|center|'''Figure 1:''' <b>Analysis of the restriction map BBa_K2278023. </b> Digested fragments (XbaI and PstI) are electrophoresed through a 1% agarose gel. Control vector pSB1C3 contained an insert and expected size were 2034 and 700 bp (digestion was not total, hence the 2734 bp fragment). The fragment lengths of the correct clones (#2 to #5) were 2035 bp and 385 bp for the required insert.]]
 +
<html>
 +
 
 
<br>
 
<br>
 
<p><b>Sequencing </p></b>
 
<p><b>Sequencing </p></b>
−
<figure><p style="text-align:center;"><img src="https://static.igem.org/mediawiki/parts/2/27/T--INSA-UPS_France--coT2seq.png" width = "700"/><figcaption>Figure 2 : <b>Sequencing  of pSB1C3-cOT2  </b> 1500 ng of plasmid are sequenced. The obtained sequence were blast on the BBa_K2278023 sequence with the iGEM sequencing online tools. </figcaption></figure>
 
  
 +
 +
</html>
 +
[[Image:T--INSA-UPS_France--coT2seq.png|800px|thumb|center|'''Figure 2:''' <b>Sequencing  of pSB1C3-cOT2  </b> 1500 ng of plasmid are sequenced. The obtained sequence were blast on the BBa_K2278023 sequence with the iGEM sequencing online tools.]]
 +
<html>
 
The sequencing successfully validated the sequence of the biobrick.  
 
The sequencing successfully validated the sequence of the biobrick.  
 
<br>
 
<br>
  
 
<h3 id="RT"> 2- Integration in <i>Pichia pastoris</i>  </h3>
 
<h3 id="RT"> 2- Integration in <i>Pichia pastoris</i>  </h3>
−
The biobrick was placed under the control of the constitutive pGAP promoter (BBa_K431009) and was cloned in the pPICZalpha vector, an expression vector for the yeast <i>Pichia pastoris</i>.  
+
The biobrick was placed under the control of the pAOXI promoter and was cloned in the pPICZalpha vector, an expression vector for the yeast <i>Pichia pastoris</i>.  
 
The plasmid was then linearized and transferred in <i>Pichia pastoris</i> by electroporation. The integration is predicted to be at the pAOXI location. Indeed, the pAOXI promoter makes genome recombination easier in <i>Pichia pastoris</i>.  
 
The plasmid was then linearized and transferred in <i>Pichia pastoris</i> by electroporation. The integration is predicted to be at the pAOXI location. Indeed, the pAOXI promoter makes genome recombination easier in <i>Pichia pastoris</i>.  
  
−
<figure><p style="text-align:center;"><img src="https://static.igem.org/mediawiki/parts/b/b1/T--INSA-UPS_France--_pcrcolony_cot2.png
+
</html>
−
"/><figcaption> Figure 3: <b>Integration of pAOXI+BBa_K2278023 in <i>Pichia pastoris</i> </b> To verify the correct integration, we performed colony PCR and electrophoresed the product through a 0.7% agarose gel. A 307 bp fragment is expected if the integration is correct.  
+
[[Image:T--INSA-UPS_France--_pcrcolony_cot2.png|800px|thumb|center|'''Figure 3:''' <b>Integration of pAOXI+BBa_K2278023 in <i>Pichia pastoris</i> </b> To verify the correct integration, we performed colony PCR and electrophoresed the product through a 1% agarose gel. A 307 bp fragment is expected if the integration is correct. ]]
−
</figcaption></figure>
+
−
Correct amplifications were observed for the 3 colonies tested and the negative control with pPICZalpha presented no band, as expected.
+
−
<br><br>
+
−
 
+
  
 +
<html>
  
 +
Correct amplifications were observed for the 2 colonies tested and the positive controls with the D-NY15 fragment as matrix (D-NY15). Negative control with pPICZalpha presented a non specific amplification band with a size inferior the 307 bp.
 
</html>
 
</html>
  
Line 56: Line 61:
 
<html>
 
<html>
 
<h3 id="RT">2. Toxicity assay  </h3>
 
<h3 id="RT">2. Toxicity assay  </h3>
−
cOT2 production was performed with <i>Pichia pastoris</i> in YPD 40 g/L glucose grown for 4 days at 30 °C with shacking. Supernatants from yeasts with or without the cOT2 encoding gene were sampled. The supernatants were used in a halo assay against <i>V. harveyi</i> as the target of cOT2. Briefly, 35mL of supernatants were freeze-dried and then resuspended in 3.5mL of water. A paper cut was soaked with one of these solutions and placed on a Petri plate inoculated with <i>V. harveyi</i> (figure 3).  
+
cOT2 production was performed with <i>Pichia pastoris</i> rown for 4 days at 30 °C with shacking in YPD 40 g/L glucose plus methanol to trigger the pAOX1 promoter. Supernatants from yeasts with or without the cOT2 encoding gene were sampled. The supernatants were used in a halo assay against <i>V. harveyi</i> as the target of cOT2. Briefly, 35mL of supernatants were freeze-dried and then resuspended in 3.5mL of water. A paper cut was soaked with one of these solutions and placed on a Petri plate inoculated with <i>V. harveyi</i> (figure 3).  
  
−
<figure><p style="text-align:center;"><img src="https://static.igem.org/mediawiki/parts/7/71/T--INSA-UPS_France--cOT2inhibition.png" width = "500"/><figcaption> Figure 4 : <b>AMP halo assay.</b> Positive control was performed with chloramphenicol (25 g/L), the negative control was performed with the empty plasmid integrated in <i>P. pastoris</i>, the assay was performed with the plasmid containing BBa_K2278023 integrated in <i>P. pastoris</i>.</figcaption></figure>
+
</html>
 +
[[Image:T--INSA-UPS_France--cOT2inhibition.png|800px|thumb|center|'''Figure 4:''' <b>AMP halo assay.</b>Positive control was performed with chloramphenicol (25 g/L), the negative control was performed with the empty plasmid integrated in <i>P. pastoris</i>, the assay was performed with the plasmid containing BBa_K2278023 integrated in <i>P. pastoris</i>.]]
 +
 
 +
<html>
  
 
<p><b>Conclusion :  </b> </p>
 
<p><b>Conclusion :  </b> </p>
−
No inhibition halo was observed around the yeast patch. The COT2 cytoxicity can not be demonstrated.
+
No inhibition halo was observed around the yeast patch. The cOT2 cytoxicity can not be demonstrated.
 
<p><b>Perspectives: </b></p>  
 
<p><b>Perspectives: </b></p>  
 
Higher concentration of yeast supernatants could be tried.
 
Higher concentration of yeast supernatants could be tried.
Line 68: Line 76:
 
</html>
 
</html>
 
===Design Notes===
 
===Design Notes===
−
A pGAP promoter is present on the pSB1C3 vector before the construction. It makes genome recombination easier in <i>Pichia pastoris</i>  genome.
 
 
<p>Part:BBa_K1800001: Alpha-Factor Secretion Signal
 
<p>Part:BBa_K1800001: Alpha-Factor Secretion Signal
  
 
===Source===
 
===Source===
−
The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of the CoT2 I proposed by Prajanban<i>et al</i>., 2011.  They had determinated the amino acid sequence by mass spectrometry analysis.  
+
The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of cOT2 proposed by Prajanban<i>et al</i>., 2011.  They had determinated the amino acid sequence by mass spectrometry analysis.  
  
  
 
===References===
 
===References===
 
Prajanban, B., Jangpromma, N., Araki, T. and Klaynongsruang, S. (2017). Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1859(5), pp.860-869.
 
Prajanban, B., Jangpromma, N., Araki, T. and Klaynongsruang, S. (2017). Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1859(5), pp.860-869.

Latest revision as of 21:38, 23 October 2017

cOT2 antimicrobial peptide with Alpha-Factor Secretion Signal

Sequence and features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 244
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Introduction

This DNA biobrick was designed in order to produce cOT2 antimicrobial peptide.

1- Biological background

Antimicrobial peptides (AMP) are phylogenetically ancient components of the innate defense of both invertebrates and vertebrates. In the context of growing bacterial antibiotic-resistance, these AMP are considered as potential new therapeutical candidates.
Crocodile ovotransferrin 2 peptide (cOT2) is an engineered peptides coming from the siamese crocodile. It bears the natural sequence of cOT1 and has been extended based on the C. siamensis transferrin amino sequence to increase its natural antimicrobial activity The peptide is a 29 amino acid residue : KKSCHTGLKKSAGWVIPIGTLVKNGIIVR. The mechanism of action of cOT2 has been observed scanning electron microscopy. This cationic and amphipathic molecules is able to attach to and insert into membrane bilayers to form pores triggering bacterial cell lysis.

2- Usage in iGEM projects

The part was designed during the Croc’n Cholera project (team INSA-UPS-France 2017). It produces the cOT2 AMP when associated with a yeast promoter. The α-factor (BBa_K1800001) sequence contains a RBS and a signal sequence to secrete the produced peptides.

Experiments

1- Molecular biology

The gene was placed under the control of an alpha factor signal. IDT performed the DNA synthesis and delivered the part as gBlock. The construct was cloned by conventional ligation into the pSB1C3 plasmid. The construction was then inserted on plasmid pPICZa and integrated in the yeast genome.


Analysis of the restriction map

Figure 1: Analysis of the restriction map BBa_K2278023. Digested fragments (XbaI and PstI) are electrophoresed through a 1% agarose gel. Control vector pSB1C3 contained an insert and expected size were 2034 and 700 bp (digestion was not total, hence the 2734 bp fragment). The fragment lengths of the correct clones (#2 to #5) were 2035 bp and 385 bp for the required insert.


Sequencing

Figure 2: Sequencing of pSB1C3-cOT2 1500 ng of plasmid are sequenced. The obtained sequence were blast on the BBa_K2278023 sequence with the iGEM sequencing online tools.

The sequencing successfully validated the sequence of the biobrick.

2- Integration in Pichia pastoris

The biobrick was placed under the control of the pAOXI promoter and was cloned in the pPICZalpha vector, an expression vector for the yeast Pichia pastoris. The plasmid was then linearized and transferred in Pichia pastoris by electroporation. The integration is predicted to be at the pAOXI location. Indeed, the pAOXI promoter makes genome recombination easier in Pichia pastoris.

Figure 3: Integration of pAOXI+BBa_K2278023 in Pichia pastoris To verify the correct integration, we performed colony PCR and electrophoresed the product through a 1% agarose gel. A 307 bp fragment is expected if the integration is correct.

Correct amplifications were observed for the 2 colonies tested and the positive controls with the D-NY15 fragment as matrix (D-NY15). Negative control with pPICZalpha presented a non specific amplification band with a size inferior the 307 bp.

Characterization

2. Toxicity assay

cOT2 production was performed with Pichia pastoris rown for 4 days at 30 °C with shacking in YPD 40 g/L glucose plus methanol to trigger the pAOX1 promoter. Supernatants from yeasts with or without the cOT2 encoding gene were sampled. The supernatants were used in a halo assay against V. harveyi as the target of cOT2. Briefly, 35mL of supernatants were freeze-dried and then resuspended in 3.5mL of water. A paper cut was soaked with one of these solutions and placed on a Petri plate inoculated with V. harveyi (figure 3).

Figure 4: AMP halo assay.Positive control was performed with chloramphenicol (25 g/L), the negative control was performed with the empty plasmid integrated in P. pastoris, the assay was performed with the plasmid containing BBa_K2278023 integrated in P. pastoris.

Conclusion :

No inhibition halo was observed around the yeast patch. The cOT2 cytoxicity can not be demonstrated.

Perspectives:

Higher concentration of yeast supernatants could be tried.

Design Notes

Part:BBa_K1800001: Alpha-Factor Secretion Signal

Source

The peptides DNA sequence has been obtained by reverse translate the amino acid sequence of cOT2 proposed by Prajanbanet al., 2011. They had determinated the amino acid sequence by mass spectrometry analysis.


References

Prajanban, B., Jangpromma, N., Araki, T. and Klaynongsruang, S. (2017). Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1859(5), pp.860-869.